Navigation Links
Wilmington Pharmaceuticals Receives FDA Approval for Orally Disintegrating Metoclopramide Tablet
Date:9/9/2009

ODT (metoclopramide HCl) is indicated as short-term therapy for adults with symptomatic, documented gastroesophageal reflux disease (GERD) who fail to respond to conventional therapy and for the relief of symptoms associated with acute and recurrent diabetic gastroparesis (diabetic gastric stasis) in adults. Therapy should not exceed 12 weeks in duration. METOZOLV ODT is contraindicated in patients with intestinal obstruction, hemorrhage, or perforation; pheochromocytoma; known sensitivity or intolerance to metoclopramide; epilepsy; or are receiving concomitant medications with extrapyramidal reactions. METOZOLV ODT should be used with caution in patients showing acute dystonic reactions, drug-induced Parkinsonism, or other extrapyramidal symptoms; neuroleptic malignant syndrome; with a prior history of depression; hypertension; congestive heart failure and ventricular arrhythmia. Patients may experience withdrawal symptoms after stopping the use of METOZOLV ODT.

In clinical studies, the most frequently reported adverse events (greater than or equal to 2% occurrence) were headache, nausea, fatigue, somnolence, and vomiting.

About Wilmington Pharmaceuticals

Wilmington Pharmaceuticals develops and out-licenses patient-friendly, fast-dissolving formulations of established medications to treat pain, cardiac conditions, and central nervous system conditions. The company engages a highly skilled alliance of experts in clinical, regulatory, manufacturing, and other key areas to achieve rapid and cost-effective approval and commercialization of its products. This unique corporate model minimizes regulatory risks while maximizing economic opportunity (www.wilmingtonpharma.com).

About Salix Pharmaceuticals

Salix Pharmaceuticals, Inc., headquartered in Morrisville, North
'/>"/>

SOURCE Wilmington Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Sanford Rose Associates Opens Wilmington, N.C. Office
2. Quintiles to Open Clinical Research Office in Wilmington, NC
3. Lexicon Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
4. Alexza Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
5. Trubion Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference
6. Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program
7. Jiangbo Pharmaceuticals Reaffirms Guidance for Fiscal 2009
8. Onyx Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
9. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
11. Adamas Pharmaceuticals to Present Data on Triple Combination Antiviral Drug Therapy for Drug-Resistant Influenza at 2009 ICAAC Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... The empty capsules market is ... population and technological innovations in the empty capsules ... catalysing the growth of the empty capsules market. ... , Scope of Report , The report will ... entrants/smaller firms to gauge the pulse of the ...
(Date:12/19/2014)... N.Y. , Dec. 18, 2014 Egenix, Inc. ... has been elected Chairman of the Board, to succeed ... and CEO, but will continue as a member of the ... he has added to the company over almost twenty years, ... The Board of Directors has established a Search Committee ...
(Date:12/17/2014)... (PRWEB) December 16, 2014 The ... since 2013, which is why IBISWorld updated its original ... continues to benefit from an intensified focus on environmental ... for new emission standards for power plants and a ... According to IBISWorld Industry Analyst Sarah Kahn, “a range ...
(Date:12/17/2014)... 2014 Achim Noack has been named ... Group. In this position, Noack will assist Jerry Stoller, ... develop marketing strategy and supervise global marketing management and ... has tremendous knowledge and experience in the crop protection ... experience and innovative thinking will be a great asset ...
Breaking Biology Technology:Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Achim Noack Joins Stoller Group as Global Vice President of Marketing and Administration 2
... of patients treated with,Myobloc(R) (Botulinum Toxin Type B) ... Solstice Neurosciences, Inc. ("Solstice"). We,support education and training ... proper use of this product as outlined in ... and routine process for monitoring and reporting,any adverse ...
... (Nasdaq: EXEL ) will release its fourth quarter ... 2008 after the markets close.,The announcement will be followed ... PT, in which Exelixis management will discuss the results ... accessed in the Event,Calendar page under Investors at ...
... Feb. 8 Alynx, Co. (OTC Bulletin Board:,AYXC) ... 100% of the,outstanding shares of MiMedx, Inc., a ... In connection with the transaction, structured as a ... of its common stock, and,approximately 3.7 million new ...
Cached Biology Technology:Solstice Neurosciences, Inc. Issues Corporate Response to FDA Early Communication 2Alynx, Co. Completes Merger With Medical Device Company MiMedx, Inc. 2Alynx, Co. Completes Merger With Medical Device Company MiMedx, Inc. 3
(Date:12/19/2014)... 2014   LaunchKey , the first decentralized mobile ... Internet of Things era, today announced the close of ... was led by Metamorphic Ventures with participation from ENIAC ... and others.  LaunchKey has raised $4 million to date, ... team and bring LaunchKey to market in 2015. ...
(Date:12/17/2014)...  HITLAB SM announced today its completion ... confirm its adherence to current U.S. Food and ... to conduct regulated smart device and smart phone ... safety and research quality. "HITLAB is ... delivery with innovative technology," said Laura Pugliese ...
(Date:12/17/2014)... DENVER , Dec. 16, 2014  Automation ... is this more evident than at international borders. ... secure document scanners have allowed veteran travelers to ... Automated Passport Control (APC) Kiosks at an increasing ... the globe. According to ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2
... nitrogen from Arctic mushrooms to plants is shedding light ... vital nutrients to their hosts. The analytical technique, developed ... of the laboratory's Ecosystems Center and his son, Erik ... be applied to nearly all conifers, oaks, beeches, birch ...
... possible, thanks to a discovery made by a team of ... new stroke death channel ?the conduit through which key chemicals ... death that disables stroke victims. , The findings were ... an editorial in next month's issue of Nature Reviews Neuroscience. ...
... Quebec's first successful combined heart/liver transplant. The patient, Patrice ... de cardiologie de Quebec (l'hôpital Laval) to the MUHC. ... a 6-hour operation on April 14, 2006 and was ... physicians, surgeons and other health care professionals. The MUHC ...
Cached Biology News:New method confirms importance of fungi in Arctic nitrogen cycle 2UBC researchers find stroke death channel 2MUHC announces a transplant first in Quebec 2